Results 221 to 230 of about 191,176 (260)
Some of the next articles are maybe not open access.

ATAC-ing human tissue Treg cells

Immunity, 2021
What defines regulatory T (Treg) cells in healthy human tissues? In this issue of Immunity, Delacher et al. describe a human follicular helper T cell-like tissue-repair Treg cell signature governed by BATF based on chromatin accessibility data and link this on a transcriptome and protein level to important functional features like CCR8 expression.
Köhne, Maren Christin   +1 more
openaire   +3 more sources

Treg cells meet their limit

Nature Immunology, 2009
T cell antigen receptor (TCR)-transgenic models have been enormously influential in studies of T cell development in the thymus, particularly in terms of positive and negative selection. New transgenic mice produced with TCR genes cloned from regulatory T cells show that TCR specificity does 'instruct' regulatory T cell fate, within limits.
Kristin A, Hogquist, Amy E, Moran
openaire   +2 more sources

Treg cells in autoimmunity: from identification to Treg-based therapies

Seminars in Immunopathology, 2019
Regulatory (Treg) cells are key regulators of inflammation and important for immune tolerance and homeostasis. A major progress has been made in the identification and classification of Treg cells. Due to technological advances, we have gained deep insights in the epigenetic regulation of Treg cells. The use of fate reporter mice allowed addressing the
Lisa, Göschl   +2 more
openaire   +2 more sources

Single-Cell Transcriptome Analysis of Treg

2022
Regulatory T-cells (Treg) are considerably heterogeneous. Thymically derived Treg (tTreg) are those, which differentiate in the thymus, while peripherally derived Treg (pTreg) differentiate from peripheral mature CD4+ T-cells. These two populations are often identified using markers such as neuropilin-1 and Helios (for tTreg) and ROR-γt (for pTreg) in ...
Benjy Jek Yang, Tan   +2 more
openaire   +2 more sources

Stubborn Tregs limit T-cell therapy

Blood, 2012
In this issue of Blood, Baba and colleagues characterize a residual pool ofCD4+CD25+Foxp3+ regulatory T cells (Tregs) surviving a nonmyeloablative conditioning regimen that undergo robust homeostatic expansion to limit the full potential of adoptive T-cell therapy (ACT) for the treatment of cancer.
Christopher A, Klebanoff   +1 more
openaire   +2 more sources

CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours

Nature, 2021
Roberta Zappasodi   +2 more
exaly  

Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

Nature Medicine, 2022
Jay Y Spiegel   +2 more
exaly  

Treg cells

2016
James Badger Wing, Shimon Sakaguchi
openaire   +1 more source

Home - About - Disclaimer - Privacy